Apex Capital Management’s Gilead Sciences GILD Stock Holding History

Apex Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$6.52M	Sell	70,936 -4,770	-6%	-$430K	0.14%	143
2015 Q4	$7.66M	Buy	75,706 +458	+0.6%	+$47.7K	0.17%	122
2015 Q3	$7.39M	Sell	75,248 -5,159	-6%	-$573K	0.17%	122
2015 Q2	$9.41M	Sell	80,407 -558	-0.7%	-$61K	0.2%	103
2015 Q1	$7.95M	Sell	80,965 -5,708	-7%	-$580K	0.19%	108
2014 Q4	$8.17M	Sell	86,673 -8,274	-9%	-$856K	0.22%	91
2014 Q3	$10.1M	Buy	94,947 +13,266	+16%	+$1.3M	0.3%	75
2014 Q2	$6.77M	Sell	81,681 -3,065	-4%	-$239K	0.21%	92
2014 Q1	$6M	Buy	84,746 +1,095	+1%	+$85.9K	0.21%	92
2013 Q4	$6.29M	Sell	83,651 -719	-0.9%	-$50.1K	0.24%	87
2013 Q3	$5.3M	Sell	84,370 -21,010	-20%	-$1.26M	0.23%	86
2013 Q2	$5.4M	Buy	+105,380	New	+$5.49M	0.26%	90

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Apex Capital Management's GILD Position: Q1 2016 in Review

Apex Capital Management reduced its Gilead Sciences (GILD) stake by 6.3% in Q1 2016, selling an estimated $430K and leaving 70,936 shares worth $6.52M. The position accounts for 0.14% of the portfolio, ranked #143.

Apex Capital Management first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $10.1M in Q3 2014. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Apex Capital Management held 70,936 shares of Gilead Sciences worth $6.52M as of Q1 2016.
Apex Capital Management sold 4,770 Gilead Sciences shares in Q1 2016, an estimated $430K.
Gilead Sciences made up 0.14% of Apex Capital Management's portfolio in Q1 2016, its #143 holding.
Apex Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
Apex Capital Management's Gilead Sciences position peaked at $10.1M in Q3 2014.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.